CAS 865363-93-5
:2′-Deoxy-4′-C-ethynyl-2-fluoroadenosine
Description:
2′-Deoxy-4′-C-ethynyl-2-fluoroadenosine, commonly referred to as a modified nucleoside, is characterized by its structural modifications that enhance its stability and bioactivity. This compound features a deoxyribose sugar backbone, with a fluorine atom at the 2′ position and an ethynyl group at the 4′ position, which contribute to its unique chemical properties. The presence of the ethynyl group can improve the compound's resistance to enzymatic degradation, making it a valuable candidate in therapeutic applications, particularly in antiviral and anticancer research. The fluorine substitution can also influence the compound's binding affinity to biological targets, potentially enhancing its efficacy. As a nucleoside analog, it may interfere with nucleic acid synthesis, thereby impacting cellular processes. Overall, 2′-Deoxy-4′-C-ethynyl-2-fluoroadenosine represents a significant modification of adenosine, with potential implications in medicinal chemistry and drug development.
Formula:C12H12FN5O3
InChI:InChI=1S/C12H12FN5O3/c1-2-12(4-19)6(20)3-7(21-12)18-5-15-8-9(14)16-11(13)17-10(8)18/h1,5-7,19-20H,3-4H2,(H2,14,16,17)/t6-,7+,12+/m0/s1
InChI key:InChIKey=IKKXOSBHLYMWAE-QRPMWFLTSA-N
SMILES:NC1=C2C(N(C=N2)[C@@H]3O[C@](C#C)(CO)[C@@H](O)C3)=NC(F)=N1
Synonyms:- E2FDA
- Adenosine, 2′-deoxy-4′-C-ethynyl-2-fluoro-
- 4′-Ethynyl-2-fluoro-2′-deoxyadenosine
- MK 8591
- 2'-Deoxy-4'-ethynyl-2-fluoroadenosine
- 4'-ethynyl-2-fluoro-2'-deoxyadenosine
- 2′-Deoxy-4′-C-ethynyl-2-fluoroadenosine
- Islatravir
- Adenosine Impurity 22
- 4'-ethynyl-2-fluoro-2'-deoxyadenosine EFDA E2FDA
- (2R,3S,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-2-ethynyl-2-(hydroxymethyl)tetrahydrofuran-3-ol
- Adenosine Related Compound
- EFdA
- Adenosine Related Compound 6 (MK-8591)
- 4'-ethynyl-2-fluoro-2'-deoxyadenosine/EFDA
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
Islatravir
CAS:<p>Islatravir (MK-8591) is an effective anti-HIV-1 agent.</p>Formula:C12H12FN5O3Purity:98.77%Color and Shape:SolidMolecular weight:293.254'-ethynyl-2-fluoro-2'-deoxyadenosine
CAS:Formula:C12H12FN5O3Purity:98%Color and Shape:SolidMolecular weight:293.2538Ref: IN-DA00H1KH
1gTo inquire5gTo inquire1mg54.00€5mg123.00€10mg159.00€25mg225.00€50mg359.00€100mgTo inquire500mgTo inquire(2R,3S,5R)-5-(6-Amino-2-Fluoro-9H-Purin-9-Yl)-2-Ethynyl-2-(Hydroxymethyl)Tetrahydrofuran-3-Ol
CAS:<p>(2R,3S,5R)-5-(6-Amino-2-Fluoro-9H-Purin-9-Yl)-2-Ethynyl-2-(Hydroxymethyl)Tetrahydrofuran-3-Ol</p>Purity:98%Molecular weight:293.25g/mol2'-Deoxy-4'-ethynyl-2-fluoroadenosine
CAS:<p>2'-Deoxy-4'-ethynyl-2-fluoroadenosine (EFdA) is an analog of adenosine. EFdA is a potent inhibitor of HIV replication, and has been shown to be effective against other viruses such as influenza virus, herpes simplex virus, and vesicular stomatitis virus. EFdA was the first nucleoside analog to show antiviral activity in tissue culture against these viruses. This drug also inhibits the synthesis of mitochondrial rRNA and reduces the formation of mitochondrial DNA in human cells by inhibiting mitochondrial DNA polymerase γ. EFdA also prevents the binding of monoclonal antibodies to human B lymphocytes, which may be due to its steric interactions with plasma RNA. This drug is metabolized by cytochrome P450 2C8 and 2C9 into a variety of metabolites that are excreted in urine as glucuronides or sulfates. EFdA has a long</p>Formula:C12H12FN5O3Purity:Min. 95%Molecular weight:293.25 g/mol




